KARACHI: The Canadian government has imposed anti-dumping duty on imports of Circular Welded Steel Pipe (CWSP) from Pakistan up to 58 percent.
On July 20, 2018, the Canadian Border Services Agency (CBSA) and Canadian International Trade Tribunal (CITT) commenced a preliminary injury and dumping inquiry against the import of Circular Welded Steel Pipe (CWSP) in the Canadian market from Pakistan, the Philippines, Turkey and Vietnam.
Subsequently on October 18, 2018, the CBSA announced its preliminary determination on margin of dumping on imports of CWSP from Pakistan and International Industries Limited (IIL).
The provisional duty was imposed at 10.1 percent for International Industries Limited (IIL) and 58 percent for other exporters in Pakistan, the said provisional dumping margin is levied until the final determination is made by CBSA which is due in January 2019.
“Despite this, there is no financial exposure to IlL for any of our exports to date to Canada. Although our sales to Canada continue for the time being, there may be a slowdown in sales depending to the final injury findings issued by CITT in February 2019,” International Industries said in a notice of Pakistan Stock Exchange.
International Industries have engaged experienced legal counsel both in Pakistan and in Canada to aggressively contest the said inquiries initiated by CBSA & CITT and are confident of a positive outcome.
Al Doc PDF File/Link
- PTCL & Ministry of Climate Change collaborate for a Green Pakistan 26-Mar-2019
- Reon announces 10 MW solar project at Bhit 26-Mar-2019
- Engro Vopak supports Hunar Foundation by Empowering the Women of Pakistan 26-Mar-2019
- Karandaaz Pakistan Launches a Portal on Financial Services Indicators for Pakistan 26-Mar-2019
- Network International and Mastercard to form strategic partnership to accelerate digital payments growth 26-Mar-2019
- Grafenia Plc acquires Artichoke Design Limited 26-Mar-2019
- DeClout Limited acquires Dhost for S$286,000 26-Mar-2019
- Wesfarmers Limited plans to acquire Lynas Corporation 26-Mar-2019
- Oxford Biomedica notes Japanese approval of Kymriah, the first CAR-T cell therapy 26-Mar-2019
- BLS International enters ‘Fortune India’s Next 500’ 26-Mar-2019